Vision Executives International Eye Care Recruitment
  • Home
  • About
  • Recruitment Services
  • Candidate Services
  • Vacancies
  • Eye Care News
  • Contact

Eye Care News

AUGUST NEWS ROUND-UP

26/8/2022

0 Comments

 
Picture
August has seen some HUGE announcements in the field of Ophthalmology which includes some amazing movements in terms of technology, but also a massive acquisition that’s set to take place this year.  ​

​Visibly becomes the First FDA Cleared Online Vision Test in the US 
 
Visibly have been developing an at-home digital vision testing platform. This month they have announced that they have received clearance from the FDA for their Visibly Digital Acuity Product (VDAP). Visibly said it is the first FDA-cleared online visual acuity test on the US market.
 
This telemedical platform has been created to expand affordable access to vision care from across the US. The platform will allow consumers to access Visibly’s on demand, self-administered visual acuity test through their phones or computers. The test takes around 6 minutes, and the results can be made visible to eye care professionals immediately. Designed for individuals between the ages of 22 – 40, this will bring able huge changes to the eye care space in the US. 
 
Alcon to acquire Aerie in 2022
 
A huge announcement was made this month to reveal that Alcon are to acquire Aerie Pharmaceuticals on another move to boost its glaucoma portfolio and significantly expand its pharmaceuticals offer. Alcon’s acquisition of Aerie Pharmaceuticals will cost $770, $15.25 per share – a premium of 37% of Aerie’s latest closing price. Since this has been approved at the highest level the acquisition is anticipated to complete by the end of 2022.
 
BVI installs first Beyeonics One System 
 
BVI have recently announced that they have installed the first Beyeonics One System at Holzman Solomon Vision Partners in Virginia. On August 17, Jonathon Solomon, MD, was the first US surgeon to offer ophthalmic surgery with the Beyeonics One platform in private practice. Since the first practice went well, Holzman Solomon Partners will be integrating this as their primary imaging platform for all ophthalmic surgery moving forward. 
 
The features of this device enable surgeons to visualise the surgical field with enhanced clarity and detail, along with performing surgery without being constrained or limited in physical movement. 
 
“The partnership with Holzman Solomon Vision Partners marks a great milestone. As the first exoscope deploying all digital imaging during surgery, Beyeonics One advances visualization during ophthalmic surgery to the next level. Digital imaging technology has become standard in many industries and we are excited to bring that to ophthalmology. This furthers BVI’s mission to drive innovation and improve patient outcomes," said Shervin Korangy, President and CEO, BVI.
 
Lensar’s ALLY Adaptive Cataract Treatment System treated first patients
 
August has seen Lensar announced that the first commercial cases have been performed using the ALLY Adaptive Cataract Treatment System in Florida, USA. Robert Winestock performed 15 laser-assisted cataract surgery cases following the recent installation of the ALLY system at his eye institute. ALLY is the next generation of eyecare surgery, leading a huge shift in practice for cataract surgeons. 
 
Over the past months, Lensar has partnered with a select few cataract surgeons and surgery facilities to integrate the system. ALLY’s size and ergonomics are dedicated to facilitate completing the entire cataract surgery procedure in a single, sterile setting—reducing the overall time and improving the experience for the patient and surgeon. Along with increased efficiencies, ALLY is designed to enable surgeons to provide improved clinical outcomes too. Its Augmented Reality and Cataract Density Imaging will provide surgeons with a new level of guidance and confidence while performing surgery.
 
Staar Collaborates with Joe Jonas to Introduce New EVO ICL 
 
For the music fans out there, you’ll be pleased to hear that Staar Surgical have announced its partnership with Joe Jonas (singer, songwriter and actor) to raise awareness of its EVO Visian Implantable Collamer Lenses. EVO is FDA approved to provide vision corrector lenses that are intended for the correction and reduction of myopia and astigmatism. 
 
You may not be aware that Joe Jonas has had myopia since childhood and it’s one of the most common vision disorders worldwide, with prevalence rapidly increasing. This month, he had the EVO lenses implemented and is now living free from contact lenses and glasses. EVO claims to provide details sharp, clear vision at all times, doesn’t induce dry eye syndrome and preserves the cornea. 
 
FDA 510(K) Clearance for Glaukos’s iStent Infinite 
 
Glaukos have announced that the iStent infinite Trabecular Micro-Bypass System has received FDA 510(k) clearance this month. The system is indicated for use as a standalone procedure to reduce elevated IOP in patients with primary open-angle glaucoma uncontrolled by prior medical and surgical therapy. 
 
The surgeon carrying out the procedure will preloade an auto-injection system with three heparin-coatin titanium stents and inject the stents across a span of 6 hours around Schlemm’s canal. After being placed, they’re designed to lower IOP through restoring the natural outflow of aqueous humor. Later this year they intend to launch activities for the iStent.

We’re anticipating that September will be a huge month for new technology, developments and equipment in the space as there are several conference, so keep your eyes peeled on our company page and turn ON those notifications to find out the latest details as soon as their release!

Comment below to share your views on the most recent news stories in the eyecare space. 
0 Comments



Leave a Reply.

    Author

    James Pickering is our Managing Director and an eye care recruitment expert who has developed an extensive client base and candidate network. He regularly writes articles about industry developments and has received numerous recommendations from industry leaders. You can also connect with James on LinkedIn to stay up to date on the latest eye care news.

    Archives

    December 2022
    October 2022
    September 2022
    August 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021

    Categories

    All
    Eye Care News

    RSS Feed

Picture

Location

Contact Us

Vision Executives Ltd
16 Market Place
Dewsbury
WF13 1AE
​United Kingdom

+44 (0) 1134900340
info@visionexecutives.com

Site Map

​Home
​
About
​Recruitment Services
​Candidate Services
Vacancies
Eye Care News
Contact
Vision Executives Ltd is a company registered in England & Wales. Company Number 13319387.
​Copyright © 2021 Vision Executives Ltd.
Click here to see our privacy policy.
  • Home
  • About
  • Recruitment Services
  • Candidate Services
  • Vacancies
  • Eye Care News
  • Contact